March 19, 2018 / 3:44 PM / 5 months ago

BRIEF-Vistagen Therapeutics Receives U.S. Patent Covering Oral Formulations Of Av-101

March 19 (Reuters) - Vistagen Therapeutics Inc:

* VISTAGEN THERAPEUTICS RECEIVES A NOTICE OF ALLOWANCE FOR ANOTHER KEY U.S. PATENT COVERING ORAL FORMULATIONS OF AV-101 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below